Discoid Eczema Treatment Market was USD 10.32 billion in 2022 and will reach USD 22.62 billion by 2030, growing at a CAGR of 10.31% during the forecast period

Head Lice Treatment Market was estimated to be worth USD 978.98 million in 2022 and USD 1,606.10 million by 2030, growing at a CAGR of 6.1% throughout that time.

Hemorrhagic Stroke Treatment Market raise at a 7.80% of CAGR worth $62.01 billion by 2029. Its categorized by Treatment, Route of Administration, End-Users & Distribution Channel

Glioblastoma Treatment Market will raise a CAGR of 9.30% & value to reach USD 4.77 billion by forecast 2029. It is categorized by treatment type, route of administration, distribution channel and end-user.

Global Gastroenteritis Treatment Market, By, Treatment (Antibiotic Therapy, Dehydration Therapy, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2029.

The Polymyalgia Rheumatica Treatment Market was valued at USD 180 million in 2021, and it would grow upto USD 513.47 million by 2029, growing at a CAGR of 14%.

The Respiratory Distress Syndrome Treatment Market is expected to witness significant growth during the forecast period. It is analyzed as treatment, route of administration, distribution channel and end-user.

Global Anesthesia Dolorosa Treatment Market, By Symptoms (Unilateral Facial Pain, Numbness Along the Trigeminal Nerve), Treatment (Gabapentin, Surgery), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies), End User (Hospitals, Laboratories, Clinics, Therapeutic Usage, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Non-Hodgkin’s Lymphoma and Chronic Lymphoma Treatment Market will grow at a CAGR of around 7.75% by 2029 meanwhile North America dominates the market

The Purpura Treatment Market is expected to grow a healthy CAGR during the forecast period by 2029. It is divided into type, treatment, route of administration, distribution channel and end-user.